CAS 361442-04-8 Kemurnian >99.0% (HPLC) API
Ruifu Chemical Supply Related Intermediates
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]heksana-2-Asam Karboksilat tert-Butil Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
sinonim | BMS-477118;Onglyza;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxy-1-Adamantyl)acetyl]-2-Azabicyclo[3.1.0]heksana-3-Carbonitrile;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxytricyclo [3.3.1.13,7]dec-1-yl)asetil]-2-Azabicyclo[3.1.0]heksana -3-Karbonitril |
Nomer CAS | 361442-04-8 |
Nomer CAT | RF-PI1991 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C18H25N3O2 |
Bobot Molekul | 315.41 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Putih |
ambune | Ciri khas |
identifikasi | A: IR B: HPLC Retention Time |
Kemurnian / Metode Analisis | > 99,0% (HPLC) |
Kejernihan Solusi Banyu | Transparan, Ora Ana Warna, Ora Ana Sing Digantung |
Analisis Saringan | 100% Lulus 80 Mesh |
Titik Lebur | 202.0~212.0 ℃ |
Mundhut ing Pangatusan | <0,50% |
Awu sulfat | <0,20% |
Rotasi spesifik | +174,0°~+186,0° |
Impurity Tunggal | <0,50% |
Total Impurities | <1.00% |
Logam abot | <10 ppm |
Arsenik (As) | <2.0ppm |
Timbal (Pb) | <1.0ppm |
Kadmium (Cd) | <1.0ppm |
Sisa Solvents | <100ppm |
Sisa Pestisida | Negatif |
Mikrobiologi | |
Total Plate Count | <1000cfu/g |
Ragi & Mold | <100cfu/g |
E. Coli | Negatif |
S. Aureus | Negatif |
Salmonella | Negatif |
Urip beting | 24 Wulan Saka Tanggal Pabrik yen disimpen kanthi bener |
Test Standar | Standar Perusahaan |
Panggunaan | API;Diabetes Mellitus Tipe 2 |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
(BMS-477118) (CAS: 361442-04-8) minangka inhibitor dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) (Ki = 0.6-1.3 nM) sing kuat, selektif, bisa dibatalake, kompetitif lan aktif sacara lisan.BMS-477118 nduweni peotential kanggo riset diabetes mellitus jinis 2.BMS-477118minangka obat diabetes jinis 2 sing bisa ngrangsang pankreas ngasilake insulin luwih akeh sawise mangan.Iki digayuh kanthi kerjasama AstraZeneca lan Bristol-Myers Squibb Company lan kalebu inhibitor DPP-IV.BMS-477118main peran liwat nyandhet degradasi GLP-l.GLP-I minangka hormon sing diprodhuksi sacara alami ing usus sawise mangan.Bisa ngatur sekresi insulin lan nguatake panggunaan glukosa ing jaringan periferal.Obat tunggal BMS-477118 bisa nambah kontrol glukosa getih lan obat gabungan BMS-477118 karo Metformin, Sulfonylurea lan Thiazolidinediones bisa nambah efek kuratif.Iki nyebabake risiko hipoglikemia sing sithik lan reaksi salabetipun padha karo plasebo, nuduhake toleransi sing luwih apik.Ing 31 Juli 2009, BMS-477118 tablet (Onglyza), obat anyar kanggo diabetes jinis 2, diteliti bebarengan lan dikembangake AstraZeneca lan Bristol-Myers Squibb disetujoni dening FDA AS.Bisa dijupuk sapisan dina kanggo nambani diabetes jinis 2 sing digabungake karo ngontrol diet lan olahraga.